KEAP1 and non-small cell lung carcinoma: KEAP1 is mutated in around 16% of non-small cell lung cancers (NSCLCs), including 12% lung squamous cell carcinomas (LUSCs)30 and 20% lung adenocarcinomas (LUADs)31.